hsa-miR-513a-5p |
Pathways in cancer |
3.3E–08 |
Wnt signalling pathway |
1.1E–07 |
Hedgehog signalling pathway |
1.7E–04 |
ErbB signalling pathway |
1.7E–04 |
Insulin signalling pathway |
2.6E–04 |
mTOR signalling pathway |
1.5E–03 |
Chemokine signalling pathway |
2.8E–03 |
TGF beta signalling pathway |
2.5E–02 |
Metabolic pathways |
4.1E–02 |
hsa-miR-513b-5p |
Pathways in cancer |
1.5E–11 |
Wnt signalling pathway |
5.4E–08 |
ErbB signalling pathway |
5.9E–07 |
Insulin signalling pathway |
6.4E–05 |
MAPK signalling pathway |
1.3E–03 |
mTOR signalling pathway |
4.3E–03 |
Hedgehog signalling pathway |
4.7E–03 |
Metabolic pathways |
4.7E–02 |
Cell cycle |
3.9E–02 |
Chemokine signalling pathway |
4.1E–02 |
TGF beta signalling pathway |
4.1E–02 |
hsa-miR-513c-5p |
Wnt signalling pathway |
9.7E–08 |
Pathways in cancer |
2.9E–07 |
MAPK signalling pathway |
7.3E–05 |
Hedgehog signalling pathway |
2.7E–04 |
ErbB signalling pathway |
3.8E–04 |
Insulin signalling pathway |
2.1E–03 |
mTOR signalling pathway |
6.4E–03 |
TGF beta signalling pathway |
3.5E–02 |